Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 29-Mar-24 4:15 PM View:  | Smisek Jeffrey A Director | Finch Therapeutics Group, I... (FNCH) | 28-Mar-24 | Sale | 6,642 | $2.57 | $17,069.90 | (12%) 55.01K to 48.37K | |
| 29-Mar-24 4:15 PM View: | Smisek Jeffrey A Director | Finch Therapeutics Group, I... (FNCH) | 28-Mar-24 | Sale | 1,600 | $2.61 | $4,176.00 | (3%) 48.37K to 46.77K | |
| 27-Nov-23 4:54 PM View: | Smisek Jeffrey A Director | Finch Therapeutics Group, I... (FNCH) | 22-Nov-23 | Sale | 1,470 | $3.64 | $5,350.80 | (3%) 56.48K to 55.01K | |
| 09-Jun-23 4:15 PM View: | Graf Susan E Director | Finch Therapeutics Group, I... (FNCH) | 09-Jun-23 | Private Purchase | 5,010 | $0.27 | $1,352.70 | 100% 0 to 5.01K | |
| 23-Feb-23 4:05 PM View: | Blaustein Marc Chief Operating Officer | Finch Therapeutics Group, I... (FNCH) | 21-Feb-23 | Sale | 4,619 | $0.38 | $1,755.22 | (14%) 32.61K to 28.0K | |
| 25-Oct-22 4:31 PM View: | Blaustein Marc Chief Operating Officer | Finch Therapeutics Group, I... (FNCH) | 21-Oct-22 | Sale | 3,636 | $1.39 | $5,054.04 | (10%) 36.25K to 32.61K | |
| 25-Oct-22 4:25 PM View: | Vittiglio Joseph Chief Business & Legal Officer | Finch Therapeutics Group, I... (FNCH) | 21-Oct-22 | Sale | 3,636 | $1.39 | $5,054.04 | (10%) 35.0K to 31.36K | |
| 15-Jun-22 5:05 PM View: | Vittiglio Joseph Chief Business & Legal Officer | Finch Therapeutics Group, I... (FNCH) | 13-Jun-22 | Grant | 35,000 | -- | -- | 100% 0 to 35.0K | |
| 15-Jun-22 5:06 PM View: | Blaustein Marc Chief Operating Officer | Finch Therapeutics Group, I... (FNCH) | 13-Jun-22 | Grant | 35,000 | -- | -- | 2800% 1.25K to 36.25K | |
| 22-Dec-21 6:21 PM View: | Haft Nicholas Director | Finch Therapeutics Group, I... (FNCH) | 20-Dec-21 | Market Purchase | 63,850 | $10.18 | $649,993.00 | 2% 3.99M to 4.06M | (7%) |
| 25-Mar-21 6:08 PM View: | Smisek Jeffrey A Director | Finch Therapeutics Group, I... (FNCH) | 23-Mar-21 | Conversion | 1,606,310 | -- | -- | 100% 0 to 1.61M | |
| 25-Mar-21 10:00 PM View: | Crestovo Investor LLC Director 10% Owner | Finch Therapeutics Group, I... (FNCH) | 23-Mar-21 | Conversion | 11,906,100 | -- | -- | 100% 0 to 11.91M | |
| 25-Mar-21 6:05 PM View: | Haft Nicholas Director | Finch Therapeutics Group, I... (FNCH) | 23-Mar-21 | Purchase | 882,351 | $17.00 | $15,000,000.00 | 28% 3.11M to 3.99M | |
| 25-Mar-21 6:04 PM View: | Ferrante Domenic J Director | Finch Therapeutics Group, I... (FNCH) | 23-Mar-21 | Conversion | 533,254 | -- | -- | 100% 0 to 533.25K | |
| 25-Mar-21 6:08 PM View: | Smisek Jeffrey A Director | Finch Therapeutics Group, I... (FNCH) | 23-Mar-21 | Purchase | 88,235 | $17.00 | $1,500,000.00 | 5% 1.61M to 1.69M | |
| 25-Mar-21 10:00 PM View: | Crestovo Investor LLC Director 10% Owner | Finch Therapeutics Group, I... (FNCH) | 23-Mar-21 | Purchase | 735,294 | $17.00 | $12,500,000.00 | 6% 11.91M to 12.64M | |
| 25-Mar-21 6:05 PM View: | Haft Nicholas Director | Finch Therapeutics Group, I... (FNCH) | 23-Mar-21 | Conversion | 3,110,710 | -- | -- | 100% 0 to 3.11M | |
| 25-Mar-21 6:04 PM View: | Ferrante Domenic J Director | Finch Therapeutics Group, I... (FNCH) | 23-Mar-21 | Purchase | 102,941 | $17.00 | $1,750,000.00 | 19% 533.25K to 636.2K |
